Loading
Kits Eyecare Ltd. Stock: price and insider trades · Canada
CA·Mcap CA$566.9M
Kits Eyecare Ltd.: what insiders have been doing
This page follows insider dealings at Kits Eyecare Ltd. as filed with SEDI. In the past year (18 October 2025 to 18 October 2026), 36 filings came from 11 insiders.
On the market, 1 insider bought (1 purchase totalling €487k) while 1 insider sold (1 sale totalling €636k). Sales outweigh purchases by €149k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €636k, sold by THOMPSON, Joseph and made public on 11 June 2026 (0.20% of market cap). Among those who bought: 1 senior executive.
Across the 2,140 companies tracked on its exchange, the median is 12 filings; at 36 filings, this issuer sits above that mark. Over the whole record (from 2026), the tally stands at 1 purchase and 1 sale.
The last insider purchase was made public on 16 October 2026, 1 day ago. Filings reach the SEDI feed a median of 21 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
36
Thresholds
n/a
Buy Volume
€487,289
1 ops. · all time
Sell Volume
€635,851
1 ops. · all time
Who traded when
BuySaleJoseph THOMPSON1 sale
Roger Hardy1 buy
Analyst consensus: bullish or bearish?
Analysts rate Kits Eyecare Ltd. Strong Buy (bullish), based on 7 analysts. Average price target: CA$22.93.
Fundamental score
Ranked 14,534 of 24,158 companies
45.4
score / 100
Value43
Quality48
FCF yld2.1%
Earn yld0.6%
EV/EBITDA·
ROE8.5%
Gross mgn36%
Net mgn1.5%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$16.67
Analyst consensus
7 analystsStrong buy
CA$19.00Target CA$22.93(+38%)CA$26.50
Income statement
RevenueCA$202.5M
Gross profitCA$72.1M36% margin
EBITDACA$8.1M4% margin
Net incomeCA$3.1M2.5% margin
Valuation
PER (trailing)98.1x
PER (forward)49.4x
P/Book7.8x
Beta0.44
Balance sheet & cash
Market capCA$566.9M
Total debtCA$15.8M
Free Cash FlowCA$11.3M
Debt / Equity7%
Profitability & ownership
ROE8.5%
ROA5.2%
% insiders58.5%
% institutions12.8%
Last declaration on 16 October 2026
Declarations36 total
50,000 shares@ CA$15.499Common SharesTSXSEDI:4792134
Canonical exit: 14 Jan 2027 (T+90)
1,016 sharesRights Restricted Share RightsTSXSEDI:4766784
1,016 sharesRights Restricted Share RightsTSXSEDI:4766782
1,016 sharesRights Restricted Share RightsTSXSEDI:4766776
1,016 sharesRights Restricted Share RightsTSXSEDI:4766773
2,524 sharesCommon SharesTSXSEDI:4756402
5,839 sharesRights Restricted Share RightsTSXSEDI:4756401
1,651 sharesCommon SharesTSXSEDI:4756400
3,819 sharesRights Restricted Share RightsTSXSEDI:4756399
2,115 sharesCommon SharesTSXSEDI:4756398
4,894 sharesRights Restricted Share RightsTSXSEDI:4756397
2,212 sharesCommon SharesTSXSEDI:4756396
5,122 sharesRights Restricted Share RightsTSXSEDI:4756395
1,610 sharesCommon SharesTSXSEDI:4756392
3,725 sharesRights Restricted Share RightsTSXSEDI:4756391
294 sharesCommon SharesTSXSEDI:4742831
827 sharesRights Restricted Share RightsTSXSEDI:4742827
827 sharesRights Restricted Share RightsTSXSEDI:4742825
270 sharesCommon SharesTSXSEDI:4742818
758 sharesRights Restricted Share RightsTSXSEDI:4742815
758 sharesRights Restricted Share RightsTSXSEDI:4742814
86 sharesCommon SharesTSXSEDI:4742811
Common SharesTSXSEDI:4742810
244 sharesRights Restricted Share RightsTSXSEDI:4742809
25 of 36 declarations
About Kits Eyecare Ltd.
Kits Eyecare Ltd. is a Canadian company focused on providing eye care products and services. It is listed on the Toronto Stock Exchange under the symbol XTSE.
